Sonnet Biotherapeutics Holdings Inc
Change company Symbol lookup
Select an option...
SONN Sonnet Biotherapeutics Holdings Inc
ID Parts Id Inc
EGAN eGain Corp
SMED Sharps Compliance Corp
CUB Cubic Corp
CHGG Chegg Inc
RIO Rio Tinto PLC
PTOS P2 Solar Inc
LUV Southwest Airlines Co
SIC Select Interior Concepts Inc
Go

Company profile

Sonnet Biotherapeutics Holdings Inc, formerly Chanticleer Holdings, Inc., an oncology-focused biotechnology company. The Company is developing targeted biologic drugs with enhanced single or bispecific mechanisms.

Price
Delayed
$2.09
Day's Change
-0.03 (-1.42%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.12
Day's Low
2.08
Volume
(Average)

Today's volume of 50,843 shares is on pace to be in-line with SONN's 10-day average volume of 537,312 shares.

50,843

Display:

Providers:

UpdateCancel
4 providers

No news found.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.